| PDF (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-313551
- DOI to cite this document:
- 10.5283/epub.31355
Abstract
Background Expression and activation of the cMET receptor have been implicated in tumor progression and resistance to chemotherapy in human pancreatic cancer. In this regard we assessed the effects of targeting cMET in pancreatic cancer models in vitro and in vivo. Methods Human (L3.6pl, BxP3, HPAF-II, MiaPaCa2) and murine (Panc02) pancreatic cancer cell lines, endothelial cells (ECs) and ...
Owner only: item control page